Cormorant Asset Management, LP 13D and 13G filings for C4 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 3:11 pm Sale | 2021-12-31 | 13G | C4 Therapeutics, Inc. CCCC | Cormorant Asset Management, LP | 0 0.000% | -2,490,065 (Position Closed) | Filing |
| 2021-02-16 3:03 pm Sale | 2020-12-31 | 13G | C4 Therapeutics, Inc. CCCC | Cormorant Asset Management, LP | 2,490,065 5.790% | -3 (-0.00%) | Filing |
| 2020-10-16 4:00 pm Purchase | 2020-10-06 | 13G | C4 Therapeutics, Inc. CCCC | Cormorant Asset Management, LP | 2,490,068 5.790% | 2,490,068 (New Position) | Filing |